Dr. Reddy’s Laboratories informs about updates

25 Feb 2025 Evaluate

Further to intimation dated November 19, 2024, on the inspection conducted by the United States Food & Drug Administration (USFDA) at API manufacturing facility (CTO-2) in Bollaram, Hyderabad, Dr. Reddy’s Laboratories has informed that the Company has received the Establishment Inspection Report (EIR). The USFDA has classified the inspection as Voluntary Action Indicated (VAI) and concluded that the inspection is ‘closed’ under 21 CFR 20.64(d)(3).

The above information is a part of company’s filings submitted to BSE.


Dr. Reddys Lab Share Price

1271.95 -5.05 (-0.40%)
05-Dec-2025 14:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1801.50
Dr. Reddys Lab 1271.95
Cipla 1517.95
Zydus Lifesciences 929.85
Lupin 2092.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×